Europe won't renew AstraZeneca, Johnson & Johnson COVID-19 vaccine contracts next year: report | Fierce Pharma
J&J, AstraZeneca explore modifying Covid vaccines in response to rare blood clot issue
U.S. Taps Johnson & Johnson to Run Troubled Vaccine Plant - The New York Times
WHO authorizes AstraZeneca's COVID vaccine for emergency use – The Denver Post
Scientists exploring possible link between Johnson & Johnson, AstraZeneca vaccine blood clot issues - ABC News
Britain PM Johnson Gets First Dose of AstraZeneca Vaccine
WHO backs AstraZeneca COVID vaccine amid clotting concerns; green lights Johnson & Johnson shots | UN News
A mix-and-match approach to COVID-19 vaccines could provide logistical and immunological benefits | PBS NewsHour
Covid-19 vaccine trials from AstraZeneca, Johnson & Johnson to restart
Will Public Trust in Johnson & Johnson COVID-19 Shot Recover? | Time
UK PM Johnson welcomes WHO support for AstraZeneca vaccine | Reuters
After AstraZeneca, Johnson & Johnson Covid-19 vaccine has blood clot concerns | Deccan Herald
British PM takes first jab of Oxford-AstraZeneca COVID-19 vaccine in London - Xinhua | English.news.cn
South Africa scraps AstraZeneca vaccine, will give J&J shots - The Boston Globe
AstraZeneca and Johnson & Johnson to resume COVID-19 vaccine trials in San Diego - The San Diego Union-Tribune
US Puts J&J In Charge of Plant that Botched COVID Vaccine, Removes AstraZeneca
COVID-19 Vaccines from Johnson & Johnson and AstraZeneca | We know the Johnson & Johnson SARS-CoV-2 vaccine is easier to transport and distribute, but how else does it differ from the mRNA
Concerns over rare clotting disorders halt use of Johnson & Johnson's COVID-19 vaccine | Science | AAAS
African Union drops AstraZeneca vaccine, which COVAX will supply | Reuters
Australia won't buy Johnson & Johnson's one-dose Covid vaccine due to AstraZeneca similarities | Vaccines and immunisation | The Guardian
AstraZeneca, Johnson & Johnson resume late-stage Covid-19 vaccine trials
